The coronavirus death toll climbed to 4,63,245, with 555 daily fatalities, according to the data updated at 8 am.
The number of people who have recuperated from the disease surged to 3,11,39,457, while the case fatality rate stands at 1.34 per cent, the data stated.
The death toll climbed to 4,62,690 with 501 fresh fatalities, including 419 from Kerala, according to the data updated at 8 am.
The death toll climbed to 4,62,189 with 340 fresh fatalities, according to the data updated at 8 am.
The death toll due to the disease has climbed to 4,61,849.
The death toll has climbed to 4,60,791 with 526 more fatalities, according to the data updated at 8 am.
India registered a record single-day spike of 1,31,968 new COVID-19 cases on Friday, pushing its infection tally to 1,30,60,542, while the death toll increased to 1,67,642 with 780 more fatalities in a day, highest since October 18, the Union health ministry data showed.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
India registered a record single-day spike of 1,26,789 new COVID-19 cases, pushing its infection tally to 1,29,28,574, while the number of active cases too went upwards to breach the nine lakh-mark again, Union Health Ministry data updated on Thursday showed.
The productivity of the Budget session was abysmal. The Lok Sabha functioned for 33% of its scheduled time (46 hours); the Rajya Sabha 24% (32 hours).
Among states and union territories, the analysis by Lahariya showed that Uttar Pradesh missed the highest number of cases. With every case reported in that state, 98 cases were missed or remained undetected.
Head of Epidemiology and Communicable diseases at the ICMR Dr Raman R Gangakhedkar said the apex health research body will begin a study on the effectiveness of the vaccine against coronavirus infection next week.
The active cases comprise 0.46 per cent of the total infections, the lowest since March 2020.
With 14,348 people testing positive for coronavirus in a day, India's total tally of COVID-19 cases rose to 3,42,46,157, while the active cases were recorded at 1,61,334, according to the Union health ministry data updated on Friday.
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
India saw a single-day rise of 12,428 new COVID-19 cases.
The death toll climbed to 4,54,269 with 561 fresh fatalities, according to the data updated at 8 am. Kerala has reconciled 399 fatalities from the previous period.
India saw a single-day rise of 16,326 new COVID-19 cases, taking the tally to 3,41,59,562, while the active cases have declined to 1,73,728, the lowest in 233 days, according to the Union health ministry's data.
Responding to a complaint by Right to Information activist Saket Gokhale, the commission said it has found no violation of the provisions of the model code in the issue.
The death toll has climbed to 4,53,042 with 231 daily fatalities, according to the data updated at 8 am.
The death toll from the pandemic climbed to 4,52,811 with the addition of 160 fatalities, showed the data updated at 8 am.
The death toll climbed to 4,52,651 with 197 fresh fatalities, according to the data updated at 8 am.
Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).
The death toll climbed to 4,52,290 with 166 fresh fatalities, according to the data updated at 8 am.
Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.
Of the 3,071 cases of Omicron variant, 1,203 have recovered or migrated, according to the data updated by the ministry at 8 am.
3,007 fresh cases of Omicron reported across 27 states and UTs.
The death toll climbed to 4,51,814 with 379 fresh fatalities, according to the data updated at 8 am.
The number of active cases comprises 1.50 per cent of the total infections, while the national COVID-19 recovery rate stands at 97.18 per cent, data updated by the ministry at 8 am showed.
The daily rise in new coronavirus infections has been below 30,000 for 18 straight days.
The COVID-19 case fatality rate has further declined to 1.52 per cent.
A person who has cancer and doesn't have any health insurance will find it difficult to buy a regular hospitalisation cover. An indemnity-based cancer plan may cover them.
Of the 1,431 patients infected with the Omicron variant of the virus so far, 374 have either recuperated or migrated, according to the ministry's data updated at 8 am.
With 21,257 people testing positive for the coronavirus infection in a day, India's total tally of cases rose to 3,39,15,569, while the number of active cases declined to 2,40,221, the lowest in 205 days, according to data updated by the Union health ministry on Friday.
It also recorded 16,764 fresh COVID-19 cases and 220 more fatalities due to the viral disease.
Out of this, Maharashtra topped the list with 167 cases followed by Delhi with 165 cases, Kerala with 57 cases and Telangana has confirmed 55 cases.
'Antibodies remain in the blood for at least seven to nine months.'
The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.
As many as 422 Omicron cases have been detected across 17 states and Union Territories in India so far and 130 of these people have recovered or migrated, according to Union health ministry data updated on Sunday.
Maharashtra has recorded a maximum of 108 Omicron cases, followed by Delhi at 79, Gujarat 43, Telangana 38, Kerala 37, Tamil Nadu 34 and Karnataka 31.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances